UBI集團訊息
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption (N Engl J Med 2019; 380:1535-1545)
It is possible that monotherapy with UB-421 could induce sustained virologic suppression without induction of resistance in HIV-infected persons
